Immunologic profiling in schizophrenia and rheumatoid arthritis.


Journal

Psychiatry research
ISSN: 1872-7123
Titre abrégé: Psychiatry Res
Pays: Ireland
ID NLM: 7911385

Informations de publication

Date de publication:
11 2022
Historique:
received: 14 02 2022
revised: 22 08 2022
accepted: 26 08 2022
pubmed: 5 9 2022
medline: 18 11 2022
entrez: 4 9 2022
Statut: ppublish

Résumé

The negative relationship between schizophrenia (SCZ) and rheumatoid arthritis (RA) has been observed for 85 years, but the mechanisms driving this association are unknown. This study analyzed differences in profiles of cytokines (IL-1β, IL-Ra, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12p70, IFNγ, TNFα), selected genes (HLA-DRB1, IL1RN, HP2), and antibodies related to gluten sensitivity (AGA-IgG, AGA-IgA), celiac disease (tTG), and systemic autoimmunity (ANA, anti-CCP, RF) in 40 subjects with SCZ, 40 with RA, and 40 healthy controls (HC). HLA-DRB1*04:01 alleles were enriched in persons with SCZ and RA compared with HC, and the HP2/HP2 genotype was 2-fold more prevalent in AGA/tTG-positive versus negative SCZ patients. Patients with SCZ demonstrated 52.5% positivity for any of the antibodies tested, compared to 90% of RA patients and 30% of HC. Cluster analysis of the cytokines revealed three clusters: one associated with SCZ marked by high levels of IL-1Ra, one associated with HC, and one associated with both SCZ and RA marked by elevated levels of IFNγ, TNFα, and IL-6. These analyses suggest that stratification of SCZ patients by cytokine profile may identify unique SCZ subgroups and enable the use of currently available cytokine-targeted treatment strategies.

Identifiants

pubmed: 36058039
pii: S0165-1781(22)00405-X
doi: 10.1016/j.psychres.2022.114812
pii:
doi:

Substances chimiques

Autoantibodies 0
Cytokines 0
HLA-DRB1 Chains 0
Interleukin-6 0
Peptides, Cyclic 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114812

Subventions

Organisme : NIAMS NIH HHS
ID : P30 AR070254
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH113617
Pays : United States
Organisme : NIAMS NIH HHS
ID : P30 AR053503
Pays : United States
Organisme : NIMH NIH HHS
ID : T32 MH014592
Pays : United States
Organisme : NIMH NIH HHS
ID : R34 MH100776
Pays : United States

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest None.

Auteurs

William W Eaton (WW)

Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, US. Electronic address: weaton@jhsph.edu.

Katrina M Rodriguez (KM)

Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, US.

Mekha A Thomas (MA)

Department of Medicine, Division of Rheumatology, Johns Hopkins School of Medicine, US.

Jeanette Johnson (J)

Department of Medicine, Division of Rheumatology, Johns Hopkins School of Medicine, US.

Monica V Talor (MV)

Department of Pathology, Johns Hopkins School of Medicine, US.

Curtis Dohan (C)

Department of Pathology and Laboratory Medicine, University of Tennessee Health Science Center, US.

Clifton O Bingham (CO)

Department of Medicine, Division of Rheumatology, Johns Hopkins School of Medicine, US.

Rashelle Musci (R)

Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, US.

Kimberly Roth (K)

Department of Community Medicine, Mercer University School of Medicine, US.

Deanna L Kelly (DL)

Maryland Psychiatric Research Center (MPRC), University of Maryland School of Medicine, US.

Daniela Cihakova (D)

Department of Pathology, Johns Hopkins School of Medicine, US.

Erika Darrah (E)

Department of Medicine, Division of Rheumatology, Johns Hopkins School of Medicine, US.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH